| Financial Year |
March 31 2023 |
| Monetary Funds |
281,565,719.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
33,374,658.21 |
| Accounts Receivable |
295,330,510.28 |
| Advances to Suppliers |
10,140,252.68 |
| Other Receivables |
4,411,891.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
100,203,153.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,973,707.88 |
| Total Current Assets |
840,006,371.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
392,671,353.59 |
| Under-construction Projects |
29,642,852.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,435,365.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,898,518.78 |
| Deferred Income Tax Assets |
114,999,293.10 |
| Other Non-Current Assets |
12,003,197.21 |
| Sub-Total of Non-Current Assets |
638,434,063.81 |
| Total Assets |
1,478,440,435.61 |
| Short-Term Loans |
100,197,762.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
189,280,452.16 |
| Accounts Payable |
209,974,010.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,625,701.13 |
| Taxes Payable |
10,660,379.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,928,485.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,842,738.25 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
596,648,935.99 |
| Long-term Loans |
60,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,784,229.03 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
122,563,947.62 |
| Total Liabilities |
719,212,883.61 |
| Paid-In Capital(Or Share Stock) |
207,679,134.00 |
| Capital Surplus |
692,053,151.41 |
| Surplus Reserve |
47,977,997.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-159,371,795.56 |
| Minority Stockholder's Interest |
1,278,680.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
757,948,871.93 |
| Owner's Equity（Stockholder's Equity） |
759,227,552.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,478,440,435.61 |
